V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10437357 | 10033201 | 1.75 | 65 | null | 2022-02-15 | 2022-02-24 | CHOP R - 21 days | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101819820 |
| 10437360 | 10033202 | 1.62 | 65 | 03 | 2017-02-21 | 2017-02-28 | CAPECITABINE + OXALIPLATIN | 02 | N | DOCETAXEL | 100095552 |
| 10437361 | 10033203 | 1.6 | 84.1 | null | 2022-04-22 | 2022-05-09 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 100007135 |
| 10437362 | 10033204 | 1.82 | 99 | null | 2021-12-27 | 2022-01-04 | Capecitabine + Oxaliplatin 21day | 02 | null | CAPECITABINE + OXALIPLATIN | 100775233 |
| 10437371 | 10033205 | 1.55 | 67.4 | Adjuvant (A) | 2018-02-04 | 2018-03-03 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100353583 |
| 10437375 | 10033206 | 1.78 | 50.5 | Palliative (P) | 2018-06-04 | 2018-06-10 | CAPECITABINE + OXALIPLATIN | 02 | N | DOCETAXEL | 100930286 |
| 10437376 | 10033207 | 1.65 | 86.8 | Curative (C) | 2019-07-04 | 2019-07-29 | CAPECITABINE + OXALIPLATIN | 02 | N | DOCETAXEL | 101399951 |
| 10437400 | 10033208 | 1.76 | 94.65 | Palliative (P) | 2019-07-14 | 2019-07-20 | CHOP R - 21 days | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100914887 |
| 10437406 | 10033209 | 1.65 | 109 | Neo-adjuvant (N) | 2021-12-16 | 2021-12-23 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 101115672 |
| 10437407 | 10033210 | 1.75 | 90 | Palliative (P) | 2016-07-27 | 2016-08-02 | CAPECITABINE + OXALIPLATIN | 02 | N | PEMBROLIZUMAB | 100966332 |
| 10437411 | 10033211 | null | 68 | null | 2016-10-07 | 2016-10-07 | IBRUTINIB | 02 | N | IBRUTINIB | 101035953 |
| 10437419 | 10033212 | 1.71 | 72 | 03 | 2018-12-28 | 2018-12-31 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100835294 |
| 10437426 | 10033213 | 1.57 | 57 | Curative (C) | 2020-08-13 | 2020-08-14 | IBRUTINIB | N | N | IBRUTINIB | 101040889 |
| 10437446 | 10033214 | 1.56 | 64.4 | Curative (C) | 2018-05-14 | 2018-05-15 | Rituximab | N | N | RITUXIMAB | 100757917 |
| 10437460 | 10033215 | 1.74 | 62.5 | 03 | null | 2021-05-03 | IBRUTINIB | N | N | IBRUTINIB | 100562630 |
| 10437461 | 10033216 | 1.7 | 81 | 03 | 2018-10-05 | 2018-10-05 | Capecitabine + Oxaliplatin 21day | 02 | N | IBRUTINIB | 101281742 |
| 10437494 | 10033217 | 1.56 | 71 | Curative (C) | 2016-05-07 | 2016-05-07 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100112815 |
| 10437503 | 10033218 | 1.53 | 86.9 | null | 2018-08-31 | 2018-09-04 | CHOP R - 21 days | 99 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100906279 |
| 10437523 | 10033219 | 1.67 | 85 | Palliative (P) | 2019-12-03 | 2019-12-21 | Capecitabine + Oxaliplatin 21day | null | null | CAPECITABINE + OXALIPLATIN | 101004026 |
| 10437533 | 10033220 | 1.69 | 82.3 | null | 2018-08-24 | 2018-09-22 | Docetaxel | 02 | null | DOCETAXEL | 100293871 |
| 10437543 | 10033221 | 1.69 | 55.6 | Curative (C) | 2016-08-01 | 2016-08-06 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 100882005 |
| 10437548 | 10033222 | 1.6 | 68.6 | Palliative (P) | 2016-11-24 | 2016-11-25 | CAPECITABINE + RT | 02 | null | CAPECITABINE | 101318650 |
| 10437554 | 10033223 | 1.58 | 83 | Palliative (P) | 2016-05-23 | 2016-05-24 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101453950 |
| 10437561 | 10033224 | 1.73 | 76 | Palliative (P) | 2019-09-18 | 2019-09-23 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 100507810 |
| 10437570 | 10033225 | 1.73 | 52.8 | Curative (C) | 2017-10-30 | 2017-11-04 | IBRUTINIB | N | N | IBRUTINIB | 100935502 |
| 10437584 | 10033226 | 1.8 | 57 | null | 2018-06-24 | 2018-07-01 | Capecitabine + Oxaliplatin 21day | 02 | null | CAPECITABINE + OXALIPLATIN | 100131258 |
| 10437595 | 10033227 | 1.54 | 49.3 | Palliative (P) | 2016-08-29 | 2016-10-09 | Docetaxel | 02 | N | DOCETAXEL | 101320785 |
| 10437602 | 10033228 | 1.87 | 107.2 | Palliative (P) | 2017-02-08 | 2017-02-19 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 100202772 |
| 10437608 | 10033229 | 1.57 | 84.3 | Palliative (P) | 2019-03-23 | 2019-04-07 | CAPECITABINE + OXALIPLATIN | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100373142 |
| 10437617 | 10033230 | 1.55 | 78.4 | Neo-adjuvant (N) | 2016-02-17 | 2016-03-07 | Docetaxel 75mg/m2 (21 day) | N | N | DOCETAXEL | 100234468 |
| 10437627 | 10033231 | 1.76 | 73.6 | Palliative (P) | 2020-08-20 | 2020-09-11 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 100850752 |
| 10437661 | 10033232 | 1.7 | 71 | null | 2022-04-07 | 2022-04-25 | CAPECITABINE + OXALIPLATIN | 02 | null | CAPECITABINE + OXALIPLATIN | 100666001 |
| 10437669 | 10033233 | 1.73 | 64.4 | Adjuvant (A) | 2018-06-10 | 2018-07-11 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 100360593 |
| 10437673 | 10033234 | 0 | 77.1 | null | 2019-05-26 | 2019-05-30 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 100501136 |
| 10437682 | 10033235 | 1.52 | 89.6 | Curative (C) | 2015-02-01 | 2015-02-09 | Capecitabine | 02 | N | CAPECITABINE | 100470797 |
| 10437688 | 10033236 | 1.73 | 73 | Neo-adjuvant (N) | 2021-09-30 | 2022-04-29 | IBRUTINIB | 02 | null | IBRUTINIB | 101205370 |
| 10437706 | 10033237 | 1.82 | 126 | null | 2018-03-18 | 2018-03-18 | Rituximab | 02 | null | RITUXIMAB | 101374907 |
| 10437720 | 10033238 | 1.57 | 0 | Neo-adjuvant (N) | 2019-06-22 | 2019-07-16 | Capecitabine + Oxaliplatin 21day | 02 | null | CAPECITABINE | 100985391 |
| 10437724 | 10033239 | 1.54 | 51.8 | null | 2018-09-18 | 2018-10-01 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 100260468 |
| 10437730 | 10033240 | 1.7 | 79.5 | Palliative (P) | null | 2018-03-16 | Rituximab | Y | N | RITUXIMAB | 101662678 |
| 10437744 | 10033241 | 1.64 | 68.65 | Palliative (P) | 2018-02-23 | 2018-07-11 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101022817 |
| 10437747 | 10033242 | 1.8 | 82.8 | Palliative (P) | 2018-01-14 | 2018-01-14 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 100396509 |
| 10437757 | 10033243 | 1.61 | 84.9 | 03 | 2019-07-02 | 2019-07-03 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 100838506 |
| 10437780 | 10033244 | 1.64 | 86.3 | Palliative (P) | null | 2020-02-27 | Capecitabine + Oxaliplatin 21day | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101439664 |
| 10437783 | 10033245 | 1.73 | 65.3 | null | null | 2019-09-25 | IBRUTINIB | 02 | null | IBRUTINIB | 101094388 |
| 10437798 | 10033246 | 1.74 | 70.8 | Palliative (P) | 2018-09-29 | 2018-09-29 | IBRUTINIB | 02 | N | IBRUTINIB | 101366609 |
| 10437831 | 10033247 | 1.8 | 0 | Curative (C) | 2017-06-26 | 2017-07-03 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100469504 |
| 10437854 | 10033248 | 1.72 | 70.2 | Adjuvant (A) | 2019-04-03 | 2019-04-12 | Capecitabine + Oxaliplatin 21day | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100039883 |
| 10437859 | 10033249 | 1.7 | 90 | Adjuvant (A) | 2019-07-12 | 2019-08-17 | CAPECITABINE + OXALIPLATIN | N | N | CAPECITABINE | 100669210 |
| 10437860 | 10033250 | null | 76.95 | null | 2022-01-14 | 2022-01-23 | CAPECITABINE + OXALIPLATIN | 02 | null | RITUXIMAB | 100462155 |